Variant report
Variant | esv3371366 |
---|---|
Chromosome Location | chr6:165177074-165186935 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550137870 | chr6:165177084-165177085 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199906011 | chr6:165177218-165177219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567371264 | chr6:165177226-165177227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371358097 | chr6:165177245-165177246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7747058 | chr6:165177313-165177314 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs572872666 | chr6:165177345-165177346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76870771 | chr6:165177351-165177352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138067143 | chr6:165177352-165177353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112568308 | chr6:165177354-165177355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147185505 | chr6:165177386-165177387 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373818620 | chr6:165177397-165177398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547721732 | chr6:165177402-165177403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113979161 | chr6:165177403-165177404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376925996 | chr6:165177450-165177451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190278725 | chr6:165177477-165177478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542711237 | chr6:165177489-165177490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559352140 | chr6:165177492-165177493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200528080 | chr6:165177508-165177509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565903414 | chr6:165177509-165177510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371482420 | chr6:165177527-165177528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551719751 | chr6:165177529-165177530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565053301 | chr6:165177573-165177574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181240233 | chr6:165177633-165177634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550510285 | chr6:165177669-165177670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138844082 | chr6:165177688-165177689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529861411 | chr6:165177698-165177699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs546695308 | chr6:165177710-165177711 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566508279 | chr6:165177717-165177718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558324601 | chr6:165177723-165177724 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369872432 | chr6:165177762-165177763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113018581 | chr6:165177765-165177766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369848369 | chr6:165177785-165177786 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375103482 | chr6:165177841-165177842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558482569 | chr6:165177854-165177855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571856571 | chr6:165177905-165177906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142827207 | chr6:165177907-165177908 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557181127 | chr6:165177932-165177933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561762033 | chr6:165177933-165177934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144484511 | chr6:165177980-165177981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186751686 | chr6:165177983-165177984 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528947366 | chr6:165177999-165178000 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1995943 | chr6:165178024-165178025 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs556122096 | chr6:165178026-165178027 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550701754 | chr6:165178064-165178065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1995942 | chr6:165178112-165178113 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs569036558 | chr6:165178205-165178206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544513969 | chr6:165178214-165178215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs199733777 | chr6:165178248-165178249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542111512 | chr6:165178360-165178361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575461583 | chr6:165178484-165178485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian cancer | 22355333 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:165171200-165177200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
2 | chr6:165172800-165177400 | Weak transcription | Brain Germinal Matrix | brain |
3 | chr6:165176600-165177600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr6:165176800-165177400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr6:165176800-165177800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr6:165176800-165178000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr6:165176800-165178200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr6:165176800-165178600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr6:165177000-165178000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr6:165177200-165177800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr6:165177200-165177800 | Enhancers | Brain Inferior Temporal Lobe | brain |
12 | chr6:165177400-165177800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr6:165177400-165178000 | Enhancers | Brain Germinal Matrix | brain |
14 | chr6:165177400-165182800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr6:165182800-165183200 | Enhancers | H9 Cell Line | embryonic stem cell |
16 | chr6:165182800-165183400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr6:165182800-165183600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
18 | chr6:165183000-165183400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr6:165183000-165183400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr6:165183000-165183600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |